Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · IEX Real-Time Price · USD

9.48

-0.32 (-3.27%)

At close: Apr 18, 2024, 4:00 PM

9.52

+0.04 (0.42%)

After-hours: Apr 18, 2024, 4:29 PM EDT

Phathom Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	554	523	467	618	962	764	-
Market Cap Growth	-	11.93%	-24.43%	-35.78%	25.98%	-	-
Enterprise Value	609	577	518	526	724	544	1
PE Ratio	-2.59	-2.59	-2.36	-4.29	-7.45	-2.99	-
PS Ratio	812.85	766.45	-	-	-	-	-
PB Ratio	-7.18	-7.18	-6.24	8.56	4.95	3.35	-
P/FCF Ratio	-3.75	-3.75	-3.16	-4.15	-13.60	-20.84	-
P/OCF Ratio	-3.80	-3.80	-3.19	-4.16	-13.81	-20.92	-
EV/Sales Ratio	892.90	846.49	-	-	-	-	-
EV/EBITDA Ratio	-3.63	-3.63	-3.05	-3.85	-5.83	-2.17	-0.84
EV/EBIT Ratio	-3.62	-3.62	-3.04	-3.84	-5.81	-2.17	-0.84
EV/FCF Ratio	-4.15	-4.15	-3.51	-3.53	-10.23	-14.83	-1.05
Debt / Equity Ratio	-6.03	-6.03	-2.76	1.27	0.25	0.10	-1.52
Debt / EBITDA Ratio	-2.76	-2.76	-1.22	-0.67	-0.39	-0.09	-1.53
Debt / FCF Ratio	-3.15	-3.15	-1.40	-0.61	-0.69	-0.64	-1.91
Quick Ratio	9.95	9.95	5.94	9.69	5.18	65.04	0.40
Current Ratio	10.25	10.25	6.12	9.86	5.25	68.20	0.41
Asset Turnover	0.00	0.00	0	0	0	0	-
Interest Coverage	-3.80	-3.80	-6.24	-20.20	-27.17	-60.08	-98.08
Return on Equity (ROE)	494.30%	494.30%	1126.60%	-121.90%	-69.00%	-225.10%	-
Return on Assets (ROA)	-76.10%	-76.10%	-108.40%	-65.50%	-49.50%	-197.70%	-
Return on Capital (ROIC)	-45.70%	-45.70%	-130.85%	-82.62%	-51.65%	-42.23%	-184.49%
Earnings Yield	-36.36%	-38.57%	-42.34%	-23.28%	-13.41%	-33.40%	-
FCF Yield	-25.11%	-26.63%	-31.60%	-24.08%	-7.35%	-4.80%	-
Buyback Yield / Dilution	-31.11%	-31.11%	-5.72%	-11.36%	-192.32%	-87.83%	-
Total Shareholder Return	-31.11%	-31.11%	-5.72%	-11.36%	-192.32%	-87.83%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).